Table 6. Exploration of heterogeneity (meta-regression): change in adverse events, peripheral neuropathy and anaemia.

Variables	Univariate P value
	Adverse events	Peripheral neuropathy	Anaemia
Study design	0.460	0.710	0.157
Pediatric patients	0.533	0.301	0.845
Daily linezolid dose	0.926	0.108	0.059*
Control group	0.873	0.554	0.765
Sample size	0.414	0.236	0.759

*, P value <0.1 was defined as statistically significant for a meta-regression.